Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Antiva Biosciences
Antiva Biosciences
Qurasense
University of Kansas Medical Center
Zydolab - Institute of Cytology and Immune Cytochemistry
Zhujiang Hospital
Verrica Pharmaceuticals Inc.
Lund University
ANRS, Emerging Infectious Diseases
Novartis
Emory University
University of Pennsylvania
University of Arizona
Vaxart
Tamir Biotechnology, Inc.
University of Pennsylvania
University of Kentucky
Fenway Community Health
Thai Red Cross AIDS Research Centre
University of Mississippi Medical Center
University of Buenos Aires
St. Jude Children's Research Hospital
University of Kentucky
Chelsea and Westminster NHS Foundation Trust
Wawer, Maria J., M.D.